Kamada Pharmaceuticals vs Khartis Therapeutics, Inc.
Kamada Pharmaceuticals vs Khartis Therapeutics, Inc., compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Kamada Pharmaceuticals is on 50/100 and Khartis Therapeutics, Inc. on 53/100.
Where each one leads
Kamada Pharmaceuticals
- funding raised: $150M against $50.0M
Khartis Therapeutics, Inc.
- our overall score: 53/100 against 50/100
- agent readiness: 50/100 against 39/100
At a glance
| Measure | Kamada Pharmaceuticals | Khartis Therapeutics, Inc. |
|---|---|---|
| What it is | Global biopharmaceutical company specializing in plasma-derived therapeutics for rare and serious conditions. | Developing oral small molecule medicines for immunological and chronic diseases. |
| Category | Biopharma, Plasma-derived therapeutics, Orphan diseases, Immunology | Biotechnology, Pharmaceuticals, Drug Discovery, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Pharmaceuticals | Platform |
| Founded | 1990 | 2021 |
| Headquarters | Rehovot, Israel | San Diego, United States |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Kamada Pharmaceuticals | Khartis Therapeutics, Inc. |
|---|---|---|
| Total funding | $150M | $50.0M |
| Latest round | Not published | Series B |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Kamada Pharmaceuticals | Khartis Therapeutics, Inc. |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 50/100 | 53/100 |
| Traction | 40/100 | 38/100 |
| Team | 70/100 | 50/100 |
| Search visibility | 14/100 | Not published |
| Quality | 58/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | D (50/100) |
| Domain ratingLink authority, 0-100 | 49/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Kamada Pharmaceuticals | Khartis Therapeutics, Inc. |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
Kamada Pharmaceuticals vs Khartis Therapeutics, Inc.: common questions
Which is better, Kamada Pharmaceuticals or Khartis Therapeutics, Inc.?
On our 0-100 score Khartis Therapeutics, Inc. rates higher (53/100 against 50/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Kamada Pharmaceuticals and Khartis Therapeutics, Inc. compare on the numbers?
Kamada Pharmaceuticals leads on funding raised ($150M against $50.0M). Khartis Therapeutics, Inc. leads on our overall score (53/100 against 50/100), agent readiness (50/100 against 39/100).
Read the full Kamada Pharmaceuticals review and pricing or the Khartis Therapeutics, Inc. review and pricing. You can also browse other Kamada Pharmaceuticals alternatives we track.